Medical device and MedTech insights, news, tips and more

Spinal Implants Market Set to Soar to Over $15B by 2020

October 14, 2015

Orthopedics - spinalimplant

Cleveland, Ohio – According to a new MarketsandMarkets research report, Spinal Implants and Spinal Devices Market – By Product, Technologies, Minimally Invasive Device, Decompression – Global Forecast to 2020, the global spinal implants and spinal devices market is expected to reach $15.73 Billion by 2020, growing at a CAGR of 5.6% from 2015 to 2020.

The spinal implants and spinal devices market, by technology, includes spinal fusion and fixation, vertebral compression fracture treatment, and motion preservation/non-fusion technologies. Based on products, the global spinal implants and spinal devices market is divided into six major segments, namely, thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, vertebral compression fracture treatment devices, motion preservation/non-fusion treatment devices, and spine bone stimulators. Bases on the type of surgery, the global spinal implants and spinal devices market is divided into two segments, namely, open surgery and minimally invasive surgery. The spinal decompression devices market, by type of procedure, covers discectomy, laminotomy/laminectomy, foraminotomy/foraminectomy, facetectomy, and corpectomy procedures.

A number of factors such as rising incidence and prevalence of spinal disorders; development of technologically advanced, safer, and cost-effective spinal devices; global rise in the old age and obese population; and rising demand for minimally invasive spine surgery are fueling the growth of the spinal implants and spinal devices market. On the other hand, stringent regulatory guidelines for the approval of new medical devices, high procedural costs, and lack of adequate reimbursements in developing countries are restricting the growth of the global spinal implants and spinal devices market.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.